Author:
Liu En-Hui,Liao Wan-Zhe,Chen Hao-Kai,Huang Xiao-Ye,Li Rui-Xuan,Liang Hao-Wen,Guo Xu-Guang
Abstract
Abstract
Introduction
Bacterial vaginitis (BV) is a common vaginal disease. Vitamin E has been shown to reduce BV by enhancing immune function, but no studies have analyzed the relationship between vitamin E and BV at different BMIs and ages.
Method
This study used 2242 participants from four cycles of NHANES 1999–2006 in American. Participants' vitamin E levels were divided into four groups, and analyses such as study population description, stratified analysis, multiple logistic regression analysis, and curve fitting were performed. To perform data processing, the researchers used the statistical package R (The R Foundation; http://www.r-project.org; version 3.6.3) and Empower Stats software (www.empowerstats.net, X&Y solutions, Inc. Boston, Massachusetts).
Result
The concentrations of serum vitamin E were negatively correlated with the risk of BV, especially when vitamin E were at 1198-5459ug/dL with (OR = -0.443, 95%CI = 0.447–0.923, P = 0.032) or without (OR = -0.521, 95%CI = 0.421–0.837, P = 0.006) adjustment for variables. At the same time, at lower levels, there was no significant association. Vitamin E supplementation may significantly reduce the risk of BV (p < 0.001). In addition, the risk of having BV decreased and then increased with increasing vitamin E concentrations at high BMI levels (p < 0.01).
Conclusion
Vitamin E at moderate to high concentrations may significantly reduce BV risk, says the study, providing clinical evidence for the prevention and the treatment of BV.
Publisher
Springer Science and Business Media LLC